Social Media Ideas for Compassionate Use

Latest updates for Compassionate Use

Fresh curated links around Compassionate use are collected here so marketers can spot useful updates and turn timely ideas into posts faster.

Post angles to try

Share the most useful takeaway for your audience.

Turn one article into a quick practical checklist.

Ask your audience how this shift affects their work.

Turn angles into scheduled posts

Fresh articles and ideas

Recent curated links from global sources. Generate one free draft from any story, then use SocialBu to schedule and refine your content calendar.

pharmexec.com /1 month ago

<![CDATA[Right–to-Try Does Not Undermine Clinical Trials]]>

Read source

pharmexec.com /1 month ago

<![CDATA[The New Capital of Care in Rare Disease]]>

Read source

khon2.com /3 weeks ago

White House bats down speculation that Trump got access to Eli Lilly obesity drug for Гўв‚¬Лњcompassionate useГўв‚¬в„ў

The retatrutide drug is manufactured by Eli Lilly and is not FDA approved, however, one person gained access to the prescription through a program that approves experimental treatm...

Read source

arizonadailyindependent.com /3 weeks ago

Biggs Introduces Right to Try Bill

Read source

pharmexec.com /1 month ago

<![CDATA[WHO Prioritizes Three Experimental Treatments for Bundibugyo Ebola Strain ]]>

Read source

psychedelicalpha.com /1 week ago

Compass Closes Out Phase 3 With 6-Month COMP006 Data, Eyes H1’27 Launch

This morning, Compass Pathways shared 26-week data from its second Phase 3 study of COMP360 psilocybin for treatment-resistant depression (TRD). The data are from Part B of COMP006...

Read source

thehindubusinessline.com /1 week ago

No bill, no payment, just compassion and hope: One World One Family’s healthcare experiment

The One World One Family Mission provides tertiary healthcare, medical education, biomedical research, nutrition and community outreach under a single ecosystem

Read source

psychedelicalpha.com /1 month ago

Psilocybin Compassionate Use in Germany: Lea Mertens and Andrea Jungaberle on the First Patients, Payers and Practicalit...

Last summer, Germany’s medicines regulator quietly green-lit a psilocybin compassionate use program, the first such pathway in the European Union (see Germany Establishes EU’s Firs...

Read source

seekingalpha.com /22 hours ago

Compass Therapeutics: A 50% Price Cut Hiding A Regulatory Mispricing Opportunity

Read source

Turn fresh research into a full content calendar

Use SocialBu to discover ideas, generate post drafts, and schedule them across your social channels.